
Advanced Micro Devices (AMD) is a high-conviction buy following its OpenAI partnership, which includes warrants with an implied price target of $600 per share. For speculative investors, biotech firm Bruce Biosciences (SPRB) has a $500 price target from a notable analyst, but the stock carries extreme risk after its recent massive price surge. Investors are hedging against economic uncertainty by moving into alternative assets, driving both Gold (XAU) to a record $4,000 per ounce and Bitcoin (BTC) to new all-time highs. The recent dip in Oracle (ORCL) stock, due to short-term AI investment costs, may offer a buying opportunity for long-term investors confident in its infrastructure strategy. Given the significant hype in the AI sector, focus on companies with strong strategic deals and be prepared for market volatility.

By John Coogan & Jordi Hays
Technology's daily show (formerly the Technology Brothers Podcast). Streaming live on X and YouTube from 11 - 2 PM PST Monday - Friday. Available on X, Apple, Spotify, and YouTube.